Arevipharma GmbH
Overview
Arevipharma GmbH is a private pharmaceutical company based in Germany, specializing in the development and manufacturing of active pharmaceutical ingredients (APIs) for various therapeutic areas. The company focuses on delivering high-quality products for both domestic and international markets.
API / Drug Master Files
Arevipharma GmbH holds 7 active (16 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- BUPRENORPHINE HYDROCHLORIDEActive2024-07-25
- ESKETAMINE HYDROCHLORIDEActive2022-11-04
- KETAMINE HYDROCHLORIDEActive2015-04-14
- DIMETHYL FUMARATEActive2014-10-16
- BUPRENORPHINEActive2013-09-23
- BUPRENORPHINE HYDROCHLORIDEActive2011-01-24
- BISOPROLOL FUMARATEActive2009-11-02
- TORASEMIDEInactive2012-02-27
- METAXALONEInactive2010-05-31
- SOTALOL HYDROCHLORIDEInactive2010-04-19
- FLUTAMIDEInactive2010-01-27
- BICALUTAMIDEInactive2008-05-13
- Metoprolol SuccinateInactive2007-12-06
- LansoprazoleInactive2007-11-20
- TRAMADOL HYDROCHLORIDEInactive2006-01-19
Showing 15 of 16 Drug Master Files.
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Arevipharma GmbH in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.